| Ident. | Authors (with country if any) | Title |
|---|
| 001100 |
Andre Pascal Kengne [Afrique du Sud, Pays-Bas, Australie] ; Sébastien Czernichow [France] ; Emmanuel Stamatakis [Royaume-Uni] ; Mark Hamer [Royaume-Uni] ; G. David Batty [Royaume-Uni] | Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: Pooling of three British Health Surveys |
| 001341 |
Andre Pascal Kengne [Afrique du Sud, Pays-Bas, Australie] ; G. David Batty [Royaume-Uni] ; Mark Hamer [Royaume-Uni] ; Emmanuel Stamatakis [Royaume-Uni] ; Sébastien Czernichow [France] | Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status: Pooled analyses of 25,979 participants from four U.K. prospective cohort studies |
| 001559 |
Mark Woodward [Royaume-Uni, États-Unis, Australie] ; Hugh Tunstall-Pedoe [Royaume-Uni] ; G. David Batty [Royaume-Uni] ; Roger Tavendale [Royaume-Uni] ; Frank B. Hu [États-Unis] ; Sebastien Czernichow [France] | The prognostic value of adipose tissue fatty acids for incident cardiovascular disease: results from 3944 subjects in the Scottish Heart Health Extended Cohort Study |
| 002339 |
Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial |
| 002427 |
G. David Batty [Royaume-Uni, Australie] ; QIANG LI [Australie] ; Sébastien Czernichow [Australie, France] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Rachel Huxley [Australie] ; Anushka Patel [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Mark Woodward [Australie, États-Unis] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie] | Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial |
